What it does / how it works
CJC-1295 (a Growth Hormone Releasing Hormone analog) acts synergistically with Ipamorelin (a selective Ghrelin/GHRP receptor agonist) to trigger the pituitary gland to release endogenous growth hormone (GH). Combining both mimics the body’s natural pulsatile secretagogue pattern for optimal recovery, body composition, and sleep quality.
| Class | GHRH + GHRP secretagogue combination |
| Typical vial | 5 mg / 5 mg blend (or 2 mg / 2 mg) |
| Reconstitution | 2–3 mL bacteriostatic water per working vial |
| Storage after mix | 2–8°C, use within 28 days |
Protocol
| Goal | Dose | How often | How long | Route |
| Recovery & Anti-Aging | 100 mcg CJC / 100 mcg Ipamorelin | Once daily (at bedtime) | 12–16 weeks | SubQ |
| Enhanced GH Release | 100 mcg CJC / 100 mcg Ipamorelin | 2 times daily (morning & night) | 12–16 weeks | SubQ |
| Cycle Off Period | None | N/A | 4–8 weeks | N/A |
| Advanced Protocol | 100–150 mcg each component | 5 days on / 2 days off | 12 weeks | SubQ |
| Maintenance | 100 mcg CJC / 100 mcg Ipamorelin | 3 times per week | Ongoing | SubQ |
Watch: Dose each component separately when calculating total volume. Administer on an empty stomach (at least 2 hours after eating, and wait 30 minutes before consuming food or carbs) to avoid blunt GH response.